Inhibition of miR-320 alleviates hepatic steatosis and dyslipidemia via suppressing the transcription of APOE in MASLD

Key Points

• The central aim is to investigate the effects of miR-320 inhibition on hepatic steatosis and dyslipidemia in MASLD.
• Inhibition of miR-320 was applied as an intervention.
• Assessment of hepatic steatosis and hyperlipidemia levels was conducted.
• Transcription of APOE was measured to evaluate its suppression.
• Inhibition of miR-320 significantly reduced hepatic steatosis.
• There was a notable decrease in hyperlipidemia following treatment.
• The treatment suggests a direct link between miR-320 inhibition and APOE transcription suppression.